Viemed Healthcare (NASDAQ:VMD) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Viemed Healthcare (NASDAQ:VMD) issued its quarterly earnings results on Monday. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05), FiscalAI reports. Viemed Healthcare had a return on equity of 10.24% and a net margin of 4.81%.The business had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million.

Viemed Healthcare Price Performance

Shares of VMD stock opened at $9.84 on Wednesday. Viemed Healthcare has a twelve month low of $6.05 and a twelve month high of $12.61. The stock has a market capitalization of $377.27 million, a price-to-earnings ratio of 26.59 and a beta of 1.10. The stock has a fifty day simple moving average of $11.16 and a two-hundred day simple moving average of $9.71. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director owned 75,518 shares of the company’s stock, valued at approximately $868,457. This trade represents a 20.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider William Frazier sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. This represents a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 20.60% of the company’s stock.

Institutional Trading of Viemed Healthcare

Hedge funds have recently bought and sold shares of the stock. Wasatch Advisors LP boosted its position in Viemed Healthcare by 18.4% during the 2nd quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after acquiring an additional 240,346 shares in the last quarter. Two Sigma Investments LP lifted its stake in shares of Viemed Healthcare by 193.7% during the 3rd quarter. Two Sigma Investments LP now owns 251,410 shares of the company’s stock worth $1,707,000 after purchasing an additional 165,797 shares during the last quarter. Rothschild Wealth LLC purchased a new stake in shares of Viemed Healthcare during the 4th quarter worth $967,000. Arrowstreet Capital Limited Partnership boosted its position in Viemed Healthcare by 50.7% during the third quarter. Arrowstreet Capital Limited Partnership now owns 352,323 shares of the company’s stock valued at $2,392,000 after purchasing an additional 118,589 shares in the last quarter. Finally, Lazard Asset Management LLC bought a new stake in Viemed Healthcare during the third quarter valued at about $636,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.